Compounded semaglutide and tirzepatide were banned in May 2025, and the FDA has been escalating enforcement against grey market peptide vendors throughout 20252026
Tirzepatide, sold under the brand name Mounjaro (for diabetes) and Zepbound (for weight loss), is a newer medication that targets two hormones instead of just one
If weight management is your primary goal, you can switch to Wegovy or Zepbound, as both are FDA-approved for weight management
We provide Certificates of Analysis (CoA) so you can proceed with confidence, knowing the compound you're working with is exactly what it claims to be
Compounded versions are now only permissible in narrow clinical circumstances such as a documented allergy to a branded excipient and must come from a licensed 503A or 503B pharmacy
Alternatively, you can also increase the interval between two doses of semaglutide to achieve the same effect